FC
PFE icon

Fairscale Capital’s Pfizer PFE Stock Holding History

Fairscale Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.1K Hold
3,280
– – 0.06% 151
2025
Q4 		$81.7K Hold
3,280
– – 0.05% 154
2025
Q3 		$83.6K Hold
3,280
– – 0.06% 156
2025
Q2 		$76.4K Hold
3,280
– – 0.06% 159
2025
Q1 		$83.1K Sell
3,280
-430
-12% -$11.3K 0.08% 136
2024
Q4 		$98.4K Sell
3,710
-2,369
-39% -$64.3K 0.08% 121
2024
Q3 		$176K Hold
6,079
– – 0.15% 82
2024
Q2 		$179K Buy
+6,079
New +$167K 0.16% 80

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fairscale Capital's PFE Position: Q1 2026 in Review

Fairscale Capital held its Pfizer (PFE) position steady in Q1 2026 at 3,280 shares worth $92.1K. The position accounts for 0.06% of the portfolio, ranked #151.

Fairscale Capital first reported a position in PFE in Q2 2024 and has held it in 8 quarters since. The position peaked at $179K in Q2 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Fairscale Capital held 3,280 shares of Pfizer worth $92.1K as of Q1 2026.
  • Fairscale Capital left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.06% of Fairscale Capital's portfolio in Q1 2026, its #151 holding.
  • Fairscale Capital first reported a position in Pfizer in Q2 2024 and has held it in 8 quarters since.
  • Fairscale Capital's Pfizer position peaked at $179K in Q2 2024.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.